Cargando…
The evolutionary trajectories of P. aeruginosa in biofilm and planktonic growth modes exposed to ciprofloxacin: beyond selection of antibiotic resistance
Ciprofloxacin (CIP) is used to treat Pseudomonas aeruginosa biofilm infections. We showed that the pathways of CIP-resistance development during exposure of biofilms and planktonic P. aeruginosa populations to subinhibitory levels of CIP depend on the mode of growth. In the present study, we analyze...
Autores principales: | Ahmed, Marwa N., Abdelsamad, Ahmed, Wassermann, Tina, Porse, Andreas, Becker, Janna, Sommer, Morten O. A., Høiby, Niels, Ciofu, Oana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381665/ https://www.ncbi.nlm.nih.gov/pubmed/32709907 http://dx.doi.org/10.1038/s41522-020-00138-8 |
Ejemplares similares
-
Hyperbaric Oxygen Sensitizes Anoxic Pseudomonas aeruginosa Biofilm to Ciprofloxacin
por: Kolpen, Mette, et al.
Publicado: (2017) -
Adjunctive S100A8/A9 Immunomodulation Hinders Ciprofloxacin Resistance in Pseudomonas aeruginosa in a Murine Biofilm Wound Model
por: Laulund, Anne S., et al.
Publicado: (2021) -
Immune Response to Biofilm Growing Pulmonary Pseudomonas aeruginosa Infection
por: Thomsen, Kim, et al.
Publicado: (2022) -
Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms
por: Gade, Peter Alexander Vistar, et al.
Publicado: (2018) -
Molecular Epidemiology of Chronic Pseudomonas aeruginosa Airway Infections in Cystic Fibrosis
por: Cramer, Nina, et al.
Publicado: (2012)